PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the Subcommittee on Terrorism, Unconventional Threats and Capabilities.
Congressional Research Service
Version 00 · Introduced in House · Jul 29, 2005
Rapid Pathogen Identification to Delivery of Cures Act - Amends the Homeland Security Act of 2002 to require the Secretary of Homeland Security to submit a report setting forth a strategy to reduce the time frame from pathogen identification to the development and emergency approval for human use of a reasonably safe and effective priority countermeasure against a novel or unknown pathogen or toxin. Requires the report to include: (1) technical impediments to reducing this time frame; (2) research, development, and technology needs to address these impediments; and (3) potential liability concerns stemming from distribution of rapidly-developed priority countermeasures.
Allows the Secretary to contract with any firm or institution to conduct necessary research and analysis for this report.
Requires the Secretary of Health and Human Services (HHS) to establish a system to rapidly: (1) establish clinical research programs to examine the safety and efficacy of treatments for novel, unknown, or bioengineered pathogens or toxins; and (2) disseminate results and recommendations to clinicians. Authorizes establishment of a fund to support such clinical research.
Showing the opening paragraphs of the official summary.
Requires the Secretary of Homeland Security to establish an interagency working group to carry out this Act.
Amends the Public Health Service Act to require the Secretary of HHS to conduct research to rapidly identify, develop, produce, and approve for human use priority countermeasures.
Requires the Secretaries of Defense and HHS to carry out research, development, and procurement to provide the federal government with the capability to rapidly identify, develop, produce, and approve for human use under emergency conditions priority countermeasures against a novel, unknown, or engineered pathogen or toxin for which no existing countermeasure has been determined to be safe or efficacious.
People & committees
Del. Christensen, Donna M. [D-VI-At Large] · D–VI
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Subcommittee on Terrorism, Unconventional Threats and Capabilities.
Referred to the Subcommittee on Emergency Preparedness, Science, and Technology.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor introductory remarks on measure. (CR E1712)
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 15, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.3627 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.3627 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.3627 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.3627 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.